Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse S100A11 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB5167SP
This item is not returnable.
View return policy
Description
S100A11 Monoclonal specifically detects S100A11 in Mouse samples. It is validated for Western Blot.Specifications
S100A11 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
P50543 | |
S100A11 | |
E. coli-derived recombinant mouse S100A11 Met1-Ile98 Accession # P50543 | |
25 μg | |
Primary | |
Detects mouse S100A11 in direct ELISAs and Western blots. In direct ELISAs, ;no cross-reactivity with recombinant mouse S100A1, 4, 6, 8, 9, 10, 13, or 16 is observed, and approximately 75% cross-reactivity with recombinant human (rh) S100A11 is observed. In Western blots, no cross-reactivity with rhS100A11 is observed | |
Mouse | |
Purified |
Western Blot | |
493804 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
calgizzarin, Metastatic lymph node gene 70 protein, MLN 70, MLN70, protein S100-A11, Protein S100-C, S100 calcium binding protein A11, S100 calcium-binding protein A11, S100 calcium-binding protein A11 (calgizzarin), S100C, S100CS100 calcium binding protein A11 (calgizzarin) | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
6282 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction